Truscreen Group Share Price and Company Fundamentals
Last traded: Today at 2:24 AM
Truscreen Group Limited, together with its subsidiaries, develops, manufactures, and sells cancer detection devices and systems in New Zealand, Mexico, China, Russia, Zimbabwe, Papua New Guinea, and internationally. The company offers the TruScreen cervical cancer screening system, a medical device for detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. Truscreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.
|Primary activities||The development, manufacture and sale of cancer detection devices and systems|
|Industry / Sector||Medical Devices / Healthcare|
|Mailing address||Equitable House Level 6 57 Symonds Street Grafton Auckland 1010 New Zealand|
|Phone / Fax||61 2 8999 3896 /|
|Share registry||LINK MARKET SERVICES LIMITED|
Truscreen Group does not pay dividends.
As of May 2021, following are the company executives and directors listed on Truscreen Group.
|Mr. Guy Adrian Robertson B.Com., C.A., B.Comm(Hons.), CA, MAICD||CFO & Company Sec.||63.97k|
|Ms. Juliet Hull M.B.A.||Interim CEO & Exec. Director|
|Mr. Paul Curran||Gen. Mang. of Quality & Regulatory Compliance|
|Mr. Edmond Capcelea||Chief Technology Officer|
|Ms. Nicole Melia||Mang. of Marketing & Communication|
|Dr. . Phunc||Head of Cancer Department|
|Dr. . Chuong||Head of R&D and Training Department|
|Dr. . Thuy||Head of High Service Gynaecology Examination|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Truscreen Group is 27.85M and its enterprise value is 23.89M. The enterprise value to revenue ratio of TRU is 13.02.
The TRU's stocks Beta value is 0.50 making it 50% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Truscreen Group (TRU)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Truscreen Group (ASX:TRU) Frequently Asked Questions
1. What is Truscreen Group's Stock Symbol?
Truscreen Group trades on ASX under the ticker symbol "TRU".
2. What is Truscreen Group's stock price today?
One share of TRU stock can currently be purchased for approximately $0.08.
3. How can I contact Truscreen Group?
Truscreen Group's mailing address is Equitable House Level 6 57 Symonds Street Grafton Auckland 1010 New Zealand. The company can be reached via phone at 61 2 8999 3896.
4. What is Truscreen Group's official website?
The official website of Truscreen Group is http://truscreen.com.
5. Which share registry manages Truscreen Group's stock?
Truscreen Group's stock is managed by LINK MARKET SERVICES LIMITED.